A retrospective cohort study assessing the effects of 200-unit Onabotulinumtoxin A detrusor injections on neurogenic detrusor Overactivity in patients who have previously been treated with 300-unit injections
Latest Information Update: 05 Aug 2021
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Neurogenic bladder; Overactive bladder
- Focus Therapeutic Use
- 05 Aug 2021 New trial record